first large study of glp-1 receptor agonists during pregnancy Trending at Annals.org: A recent more than 3,500 pregnancies found that continuing the trimester was not associated with a substantially increased risk for loss first large study of glp-1

[PMID: 15658444] PubMed record related to this compound for laboratory literature review

At doses of up to 30 micrograms per kilogram (g/kg), researchers noted that CJC-1295 DAC caused the following side effects: Mild injection site reactions Itching Headaches Pain Diarrhea Hypertension Induration The studys authors noted that around 70 percent of the test subjects who received CJC-1295 DAC experienced one or more of these side effects and that the severity of the reactions increased with doses over 30 g/kg

Clear glass vials exposed to standard laboratory lighting lose 1015% potency within 14 days even when refrigerated

There is no single best option for everyone

23 However, prolonged use may still induce subclinical hepatic stress, especially in individuals with pre-existing metabolic disorders or other risk factors

Human trials are needed to confirm its safety and effectiveness before widespread clinical use